CD19 t-haNK

· ImmunityBio, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CD19 t-haNK, covering 2025-02-21 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma [Phase 2]